The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

DPP4 inhibitors and SGLT2 inhibitors. Compared to usual care, GLP-1RA use was linked to a reduced risk of various neurocognitive disorders, substance use and psychotic disorders, seizures ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...

Slight body weight and systolic blood pressure reduction are important beneficial effects. Main adverse events of SGLT2 inhibitors are genital mycotic and urinary tract infections. Dapagliflozin ...

or in the the APC or APPROVE trials. Controversy about the mechanisms of potential cardiovascular side effects of COX inhibitors and NSAIDs persists. Intriguingly, the sulfone COX2 inhibitors ...

Blood thinners prescribed after blood clots in the leg or lung initially increase the risk of bleeding, especially in women ...

It may cause mild side effects, such as abdominal pain ... such as statins or angiotensin converting enzyme (ACE) inhibitors, may cause hair loss. If you’re experiencing hair loss, contact ...

A trio of VFX Oscar nominees lead the feature competition nominations for the 23rd Visual Effects Society Awards, which will be handed out Feb. 11 at the Beverly Hilton. Denis Villeneuve’s ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Jackie Reeve Jackie Reeve is a writer covering all things bedding.